Chlorhexidine: it works. Just not the way you think

Most people use chlorhexidine incorrectly — not because they read bad instructions, but because the correct instructions run against intuition. The drug works so well that this is precisely where the problem starts.

If a dentist prescribed a chlorhexidine rinse after an extraction or for gingivitis treatment — that's exactly right. If you're buying it "just in case" and rinsing every day for months — that's a different story.

Why "kills everything" isn't always good

Chlorhexidine's mechanism is physical, not chemical. The molecule carries a positive charge and is attracted to the negatively charged membranes of bacteria. At low concentrations it disrupts osmotic balance — the cell leaks its contents. At high concentrations it ruptures the membrane outright. This is why resistance doesn't develop in the classic sense: there's no single molecular target for bacteria to mutate around.

The problem is that the mouth isn't a sterile operating room. About 700 bacterial species live there. Among them are nitrate-reducing anaerobes, predominantly from the genus Bacteroidetes. Their role in the ecosystem: convert dietary nitrate (spinach, beetroot, rocket) into nitrite in saliva. That nitrite, in the stomach and tissues, is partially converted into nitric oxide — NO.

Nitric oxide relaxes vessel walls, reduces peripheral resistance, and helps regulate arterial pressure. This route — dietary nitrate → oral bacteria → salivary nitrite → systemic NO — is called the enterosalivary pathway. By various estimates, it accounts for up to ~25% of systemic NO production.

Chlorhexidine kills these bacteria efficiently and indiscriminately.

What the data actually show

A systematic review by Van Strydonck et al. (2012, 30 publications) documented real efficacy of a chlorhexidine rinse in gingivitis patients: plaque reduced by approximately 33%, gingival inflammation by 26%. Alongside it, a consistent finding: tooth staining — brownish deposits that water alone won't remove. The larger 2017 Cochrane review (James et al., 51 RCTs, 5,345 participants) confirms the picture qualitatively: a large reduction in plaque (SMD 1.45, 95% CI 1.00–1.90), a small reduction in gingival index (a 0.21-point difference, 95% CI 0.11–0.31 — which the authors call not clinically relevant), and a consistent, significant increase in tooth staining (SMD 1.07).

"Chlorhexidine mouthrinses reduce dental plaque and gingivitis with statistical significance, but are accompanied by side effects including staining and altered taste sensation."

— James et al., Cochrane Database Syst Rev, 2017 (PMID: 28362061)

Bescos et al. (Scientific Reports, 2020) ran a single-blind, cross-over study (not randomised) in 36 healthy volunteers: 7 days of chlorhexidine rinsing caused a rise in Firmicutes and Proteobacteria, a fall in Bacteroidetes, and lower salivary pH. Salivary and plasma nitrite dropped significantly (p<0.05). Oral nitrate reduction was suppressed by at least 80% (a figure drawn from earlier work the authors cite). Systolic blood pressure showed an upward trend that did not reach significance.

Price et al. (SuDDICU, BMJ, 2014), in a systematic review with network meta-analysis of intensive-care patients, found an association between chlorhexidine oral care and increased mortality: OR 1.25 (95% CI 1.05–1.50). The later review by Blot (Intensive Care Med, 2020) cites the same figure. One proposed mechanism: suppression of the oral NO pathway.

Katz and Garcia (Quintessence International, 2025) analysed a large hospital cohort (October 2015 – May 2024, NIH i2b2 platform): patients with a history of chlorhexidine rinsing showed elevated odds for a diagnosis of primary arterial hypertension (OR around 3.0, 95% CI 3.03–3.16). Observational, not experimental — but it adds an epidemiological layer to the mechanistic picture.

Concentrations from 0.01% to 0.2% — what actually changes

The 2010 meta-analysis by Berchier et al. compared 0.12% with 0.2% and found the plaque index difference was WMD 0.10 (95% CI 0.03–0.17, p=0.008) in favour of 0.2% — statistically significant, clinically negligible. An experimental gingivitis RCT by Haydari et al. (BMC Oral Health, 2017, PMC5562977) found no significant difference between 0.06% and 0.12%, while 0.2% gave statistically significantly the lowest plaque scores (i.e. it suppressed plaque most strongly). There was no difference in tooth staining between the groups — the main downsides of 0.2% were loss of taste (reported by 65% versus 21% in the 0.06% group) and numbness, not staining. The takeaway: a higher concentration works slightly harder, but the price is side effects rather than a clinically meaningful gain.

Parameter	0.01%	0.05%	0.12%	0.2%
Efficacy against plaque	Minimal (sub-therapeutic)	Moderate	High	High
Substantivity (retention)	Data limited	Data limited	~5 h (measured in vivo), up to ~12 h anti-plaque	~7 h (measured in vivo), up to ~12 h anti-plaque
Risk of tooth staining	Virtually none	Lower	High	Maximum
Taste disturbance	None	Mild	Moderate	Pronounced, may last several days
Impact on microbiome	Negligible	Less pronounced	Pronounced	Pronounced
Typical use	Freshening formulas; prophylactic use in some markets	Adjunct with braces, implants	Acute gingivitis, post-surgical period	Post-surgical care (UK/EU standard)
Recommended course	Usually 1–2 weeks, max 2–4 weeks	Usually 1–2 weeks, max 2–4 weeks	Usually 1–2 weeks, max 2–4 weeks	Usually 1–2 weeks, max 2–4 weeks (up to 30 days under UK licence)
Patients with hypertension	Insufficient data	With caution	Only under medical supervision	Only under medical supervision

The central point: none of these concentrations is designed for permanent use in place of a regular mouthwash.

What to use instead for daily prevention

Cetylpyridinium chloride (CPC). A quaternary ammonium compound with proven antibacterial action. The systematic review by Haps et al. (2008, PMID 19138180) found a small but statistically significant benefit against plaque and gingival inflammation when used alongside tooth brushing. Does not suppress nitrate-reducing bacteria to the same degree.

Essential oils (thymol, menthol, eucalyptol, methyl salicylate). Short-term evidence base is comparable to chlorhexidine — with virtually no staining and no data on interference with the enterosalivary pathway.

A practical point that's often overlooked: the culprit isn't fluoride. Fluoride on its own doesn't deactivate chlorhexidine — Villa et al. (Clin Oral Investig, 2018, PMID 29032402) showed CHX + NaF and CHX alone produce the same effect. The real conflict is with anionic SLS (sodium lauryl sulfate), the foaming agent in most toothpastes: positively charged chlorhexidine binds to it into a poorly soluble compound and loses activity. So if you are using chlorhexidine as a short course, separate it from brushing with an SLS toothpaste: at least 30 minutes, ideally around 2 hours.

Chlorhexidine is not a hygiene product. It's a drug for acute clinical situations. That's precisely how it should be used.

What this means in practice

Chlorhexidine works. That's exactly why you can't use it constantly.

Acute gingivitis, post-surgical oral rehabilitation, a temporary inability to brush normally — chlorhexidine is justified here. A course of 7–14 days, on professional advice.

As a daily rinse "for prevention," or with hypertension without medical supervision, or in long courses without a clinical indication — here chlorhexidine is excessive or actively harmful.

---

FAQ

Can you use chlorhexidine mouthwash every day?

No. Chlorhexidine is designed for short courses (7–14 days) at specific clinical indications. Continuous use suppresses beneficial bacteria, disrupts the oral microbiome, and through the enterosalivary pathway reduces systemic nitric oxide production.

Which is better — chlorhexidine 0.12% or 0.05%?

For acute situations (gingivitis, post-surgical) — 0.12% is more effective. For longer-term gentle use with braces or implants — 0.05% produces fewer side effects at comparable results. Neither is a substitute for a standard daily mouthwash.

Is there a link between chlorhexidine and high blood pressure?

Data exist, but are not conclusive. Mechanistic research (Bescos et al., 2020) showed that 7 days of use suppresses oral nitrate reduction by at least 80% and causes a trend toward higher blood pressure. A 2025 epidemiological study (Katz, Garcia) found an association with hypertension diagnosis in a large cohort. Patients with hypertension should discuss use with their doctor.

What can replace chlorhexidine for daily rinsing?

Cetylpyridinium chloride (CPC) or essential oil mouthwashes. Both have an evidence base for efficacy against plaque and gingivitis, without systemic effects on nitric oxide synthesis.

---

References:

1. Van Strydonck DA, Slot DE, Van der Velden U, Van der Weijden GA. Effect of a chlorhexidine mouthrinse on plaque, gingival inflammation and staining in gingivitis patients: a systematic review. J Clin Periodontol. 2012;39(11):1042-1055. (PMID: 22957711)

2. James P, Worthington HV, Parnell C, et al. Chlorhexidine mouthrinse as an adjunctive treatment for gingival health. Cochrane Database Syst Rev. 2017. DOI: 10.1002/14651858.CD008676.pub2 (PMID: 28362061)

3. Bescos R, Ashworth A, Cutler C, et al. Effects of chlorhexidine mouthwash on the oral microbiome. Scientific Reports. 2020. DOI: 10.1038/s41598-020-61912-4 (PMID: 32210245; PMC7093448)

4. Price R, MacLennan G, Glen J; SuDDICU Collaboration. Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. BMJ. 2014;348:g2197. DOI: 10.1136/bmj.g2197 (PMID: 24687313)

5. Katz J, Garcia I. The use of chlorhexidine mouthwash and diagnosis of primary hypertension in a large hospital cohort. Quintessence Int. 2025;56(2):138-142. (PMID: 39639848)

6. Berchier CE, Slot DE, Van der Weijden GA. The efficacy of 0.12% chlorhexidine mouthrinse compared with 0.2% on plaque accumulation and periodontal parameters: a systematic review. J Clin Periodontol. 2010;37(9):829-839. (PMID: 20618550)

7. Haydari M, Bardakci AG, Koldsland OC, Aass AM, Sandvik L, Preus HR. Comparing the effect of 0.06%-, 0.12% and 0.2% Chlorhexidine on plaque, bleeding and side effects in an experimental gingivitis model. BMC Oral Health. 2017. (PMC5562977)

8. Cousido MC, Tomás Carmona I, García-Caballero L, et al. In vivo substantivity of 0.12% and 0.2% chlorhexidine mouthrinses on salivary bacteria. Clin Oral Investig. 2010. (PMID: 19662444)

9. Villa O, Ramberg P, Fukui H, et al. Interaction between chlorhexidine and fluoride in a mouthrinse solution. Clin Oral Investig. 2018. (PMID: 29032402)

10. Haps S, Slot DE, Berchier CE, Van der Weijden GA. The effect of cetylpyridinium chloride-containing mouth rinses as adjuncts to toothbrushing on plaque and parameters of gingival inflammation: a systematic review. Int J Dent Hyg. 2008. (PMID: 19138180)

11. Bartsch S, Kohnert E, Kreutz C, Woelber JP, et al. Chlorhexidine digluconate mouthwash alters the oral microbial composition and affects the prevalence of antimicrobial resistance genes. Front Microbiol. 2024. DOI: 10.3389/fmicb.2024.1429692 (PMID: 38983634)

12. Dewhirst FE, Chen T, Izard J, et al. The Human Oral Microbiome. J Bacteriol. 2010;192(19):5002-5017. (PMC2944498)